Irreversible Inhibition of IspG, a Target for the Development of New Antimicrobials, by a 2‐Vinyl Analogue of its MEcPP Substrate - Groupe Synchrotron / Synchrotron Group (IBS-GSY) Access content directly
Journal Articles Chemistry - A European Journal Year : 2022

Irreversible Inhibition of IspG, a Target for the Development of New Antimicrobials, by a 2‐Vinyl Analogue of its MEcPP Substrate

Abstract

IspG (also called GcpE) is an oxygen-sensitive [4Fe-4S] enzyme catalyzing the penultimate step of the methylerythritol phosphate (MEP) pathway, a validated target for drug development. It converts 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate (MEcPP) into (E)-4-hydroxy-3-methyl-but-2-enyl-1-diphosphate (HMBPP). The reaction, assimilated to a reductive dehydration, involves redox partners responsible for the formal transfer of two electrons to substrate MEcPP. The 2-vinyl analogue of MEcPP was designed to generate conjugated species during enzyme catalysis, with the aim of providing new reactive centers to be covalently trapped by neighboring amino acid residues. The synthesized substrate analogue displayed irreversible inhibition towards IspG. Furthermore, we have shown that electron transfer occurs prior to inhibition; this might designate conjugated intermediates as probable affinity tags through covalent interaction at the catalytic site. This is the first report of an irreversible inhibitor of the IspG metalloenzyme.
Fichier principal
Vignette du fichier
Text-revision-Final version à nous.pdf (2.02 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03845648 , version 1 (09-11-2022)

Identifiers

Cite

Vivien Herrscher, Clea Witjaksono, Marie Buchotte, Claire Ferret, Fabien Massicot, et al.. Irreversible Inhibition of IspG, a Target for the Development of New Antimicrobials, by a 2‐Vinyl Analogue of its MEcPP Substrate. Chemistry - A European Journal, 2022, 28 (30), pp.e202200241. ⟨10.1002/chem.202200241⟩. ⟨hal-03845648⟩
40 View
58 Download

Altmetric

Share

Gmail Facebook X LinkedIn More